济南阴茎头敏感度高怎么办(济南阴茎勃起硬度不硬) (今日更新中)

When a rumor of a mass shooting trickled out late Wednesday evening, play director Brett Elliott was putting the finishing touches on a student production.“Immediately people started panicking and crying, not knowing who to reach out to first because all of their friends could have been there,” Elliott describes.Elliott was set to direct a play about the Columbine High School shooting with student actors at California Lutheran University. The play “Columbinus” was based on the events that took place in the 1999 shooting in Columbine, Colorado.“I was sitting right over here to your right, giving final notes and instructions to my actors, literally on how to effectively portray people affected by a mass shooting, Elliott says.“We thought it was vital three days ago. We thought it was immediate three days ago. Now, it’s on our doorstep.”One of his cast members did, in fact, lose a best friend.“I've spent a month and half with these kids, trying to teach them what it could be like to experience an event like this, try to help them get into the minds of people, of a community affected by an event like this,” Elliott says. “I would never in a million years have wished for them to actually live it. It’s heartbreaking.”This weekend's opening performances have been canceled. The future of the production is unclear.However, Elliott and the cast unanimously agree that it should go on."It is exponentially more important to us all now," Elliott says.Whether the play will go on is up to the university. But if theatre's job is to hold a mirror up to nature, to society, Elliott believes the show must go on, especially now.“This show is why we do theatre,” Elliott says. “This show is why theatre exists.” 1724

When you go out to eat or visit the grocery store, you’ll probably spot an employee wiping down tables or spraying carts with disinfectant. These sanitizers can kill the novel coronavirus, but doctors warn some can also cause chemical burns and allergic reactions on your skin.“Depending on the strength of these disinfectants, they can cause damage to the skin. They can react like a burn would, which can appear with significant redness or swelling to the skin,” said Dr. Frederick Davis, who works in the emergency department at the Long Island Jewish Medical Center.One Florida family believes their baby got a chemical burn after sitting in a Walmart cart sprayed with disinfectant.Davis said alcohol, bleach and ammonia, often used in commercial sanitizers, can create that reaction.“A lot of these cases, unfortunately, happen because people think it’s a disinfectant, it kills bacteria and viruses, it’s safe to apply to the skin, but it definitely isn’t,” he said.Environmental Biology Professor at the University of Arizona Dr. Charles Gerba said commercial disinfectant can be harmful to skin until it dries completely.“You don’t want to put the child down in the seat if it’s wet with disinfectant,” warned Gerba.Parents should dry carts or any surface covered in disinfectant before letting kids touch them, but experts caution, disinfectants may not work properly if they cannot dry on their own.So, to keep your kids safe and kill the germs, Dr. Gerba recommends placing a towel down in the cart or using a baby wipe to remove harsh chemicals that can build up over time.“That’s one of my concerns,” said Gerba. “You keep adding these chemical disinfectants on every single day, they’re subject to misuse, like not drying enough, so you might get some exposure,” he said.Because of these dangers, Dr. Gerba is experimenting with a replacement for commercial grade sanitizers with a company called Allied Bioscience. It’s a spray coating that sticks to any surface, even touch screens, and kills bacteria and viruses for months at a time.“It’s the same principle as odor eater socks,” said Gerba. “The reason the socks didn’t smell is it killed the bacteria that caused the odors,” he explained.Michael Ruley is the CEO of Allied Bioscience and said he hopes this coating will make its way onto airplanes, into schools and grocery stores soon. “With this coating going down, it gets ahead of the threat and is proactive instead of reactive,” Ruley said.This new technology is still getting approved by the EPA, but studies show it can fight the coronavirus.“They killed the coronavirus pretty well, like 99 percent or more, within a few minutes sometimes,” Gerba said.This product needs to be applied once every 90 days to remain effective, which would lift much of the workload off employees to clean places.“That’s the whole goal is to get people back feeling comfortable in the environment and be able to go out and enjoy their environment,” said Ruley.But until the frequent sanitizing ends, Dr. Gerba warns just because a surface is clean, doesn’t mean it’s safe for you or your kids to touch. He said the best way to protect your skin is to immediately wash your hands after touching anything that’s been sanitized. 3243

When Sgt. Brian Maynard pulled over Laura and Jimmy Baker, he was preparing to deliver a ticket. Instead, the state trooper summoned an EMS team, which delivered the couple's baby girl on the side of North Carolina's US 64 highway.It all began Saturday night in suburban Raleigh when Laura Baker got in a minivan with her husband for a visit to the hospital to check on some contractions she'd been having. Then, 10 minutes into their drive, she suddenly went to labor."I said, 'I cannot control this, we're not going to make it there,'" Baker said.So when her husband spotted Maynard's patrol car, he did everything he could to get the officer's attention, speeding and flicking his lights."As soon as we pulled over, my water broke," Baker said. "And my husband jumped out with his arms up, saying, 'My wife's in labor and I really need help.'"All three knew they didn't have time to get to a hospital. Maynard called the EMS team in nearby Wendell but was prepared to do the job himself."I said, 'OK, well, we're going to do this right here, me and you,'" he told CNN affiliate WSOC.So Baker's husband and Maynard held the mother's hands and urged her to wait for the EMS team."My husband and the trooper were nervous, because they certainly weren't prepared," she said. And when the EMS team arrived, everyone realized they couldn't get Baker on a stretcher. So she delivered in the front seat of the van.It was this team -- as well as the trooper's assistance -- that Baker said she's most thankful for."Without them, I don't know how successful it would have been," she said. "It was maybe a five-minute experience, but a vital five-minute experience. [The EMS team] did everything to make sure it was sanitary and healthy."Baker was taking her baby, Halyn, home Monday and was planning on paying a visit to the EMS team that helped keep her infant daughter healthy throughout the delivery. She doesn't know much about the EMS crew, but she'll be looking for Charlie and Danny, who held her hands throughout the birth and walked her through every step."She was born outside in 40-degree weather, but she's a perfect, healthy little girl," she said. "They did everything perfect." 2198

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

While it has been suggested to hold a vigil in the Memorial, we are asking that we stand together to confront hate - BUT NOT physically stand together in the Memorial. Let us each stand up and be a force of goodness. Let us stand together as a community of compassion.— Wassmuth Center (@IdaHumanRights) December 9, 2020 337

来源：资阳报